UBS Group’s AfterNext HealthTech Acquisition Corp Units AFTR.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,203
Closed -$22.6K 10191
2023
Q1
$22.6K Sell
2,203
-813
-27% -$8.25K ﹤0.01% 6992
2022
Q4
$30.2K Sell
3,016
-456
-13% -$4.52K ﹤0.01% 7238
2022
Q3
$34K Buy
3,472
+7
+0.2% +$69 ﹤0.01% 6748
2022
Q2
$34K Buy
3,465
+1,666
+93% +$16.3K ﹤0.01% 6286
2022
Q1
$18K Buy
1,799
+1,223
+212% +$12K ﹤0.01% 7607
2021
Q4
$6K Buy
+576
New +$5.76K ﹤0.01% 9322

Other funds holding AFTR.U

UBS Group's AFTR.U Position: Q2 2023 in Review

UBS Group sold out of AfterNext HealthTech Acquisition Corp Units (AFTR.U) in Q2 2023, closing a stake of 2,203 shares — an estimated $22.6K sold.

UBS Group first reported a position in AFTR.U in Q4 2021 and held it in 6 quarters. The position peaked at $34K in Q3 2022. 8 funds tracked by Wall St. Rank hold AFTR.U as of Q2 2023.

  • UBS Group reported no remaining AfterNext HealthTech Acquisition Corp Units position as of Q2 2023 after selling out during the quarter.
  • UBS Group sold 2,203 AfterNext HealthTech Acquisition Corp Units shares in Q2 2023, an estimated $22.6K.
  • UBS Group first reported a position in AfterNext HealthTech Acquisition Corp Units in Q4 2021 and held it in 6 quarters.
  • UBS Group's AfterNext HealthTech Acquisition Corp Units position peaked at $34K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held AfterNext HealthTech Acquisition Corp Units as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.